References
- Boulat T, Ghosn W, Morgand C, Falissard L, Roussel S, Rey G. Main trends in cause-specific mortality in mainland France between 2000 and 2016. Bull Epidemiol Hebd. 2019;29–30:576–584.
- Zins M, Goldberg M; CONSTANCES team. The French CONSTANCES population-based cohort: design, inclusion and follow-up. Eur J Epidemiol. 2015;30(12):1317–1328. doi:10.1007/s10654-015-0096-4
- Dibie A, Femery V, Dubois A, et al. VIVOPTIM: retour d’expérience d’un programme expérimental de esanté et de prévention primaire du risque cardiovasculaire global chez des sujets volontaires âgés de 30 à 70 ans [VIVOPTIM: feedback of an e-health experimental program of primary prevention of cardiovascular risk on 30 to 70 years old volunteers]. Ann Cardiol Angeiol. 2018;67:293–299.
- Available from: www.vivoptim.com. Accessed October 18, 2021.
- D’Agostino RB Sr, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743–753. doi:10.1161/CIRCULATIONAHA.107.699579
- Conroy RM, Pyorala K, Sans S, Menotti A, De Backer G, Ducimetière P. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24:987–1003. doi:10.1016/S0195-668X(03)00114-3
- Blacher J, Femery V, Thorez F, et al. A novel personalized approach to cardiovascular prevention: the VIVOPTIM programme. Arch Cardiovasc Dis. 2020;113:590–596. doi:10.1016/j.acvd.2020.02.005